Evolent Health, Inc EVH
3.61
0.09
2.56%
as of 25 Sep
- Market cap
- $398.0M
- P/E
- 0.0×
Follow EVH
Insider Buys
alert about insiders buying in the last 12 month
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
|
+8 more TTM periods Free account |
(19.23%) | (81.81%) | (80.15%) | (79.90%) | |
| (7.30%) | (26.08%) | (23.55%) | (23.05%) | ||
ROIC |
(0.73%) | (21.22%) | (21.76%) | (22.06%) | |
Return on Tangible Assets |
(82.13%) | (286.98%) | (264.31%) | (256.04%) | |
Average Days of Receivables |
68.69 | 60.28 | 60.71 | 78.17 | |
Free Cash Flow per Share |
(0.60) | 0.04 | 0.01 | 0.22 | |
Free Cash Flow |
(68.67) | 4.76 | 1.40 | 24.34 | |
Capital Expenditures |
(32.48) | (34.09) | (31.90) | (29.98) | |
Piotroski F-Score |
3.00 | 4.00 | 4.00 | 5.00 | |
| Other line items | |||||
Cash ROIC |
(1.78%) | 2.48% | 2.17% | 3.65% | |
Accounts Receivable Turnover |
5.17 | 5.18 | 5.07 | 5.19 | |
Accounts Payable Turnover |
27.41 | 18.95 | 24.96 | 32.05 | |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
15.72 | 14.78 | 15.25 | 8.17 | |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.01 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
13.58% | 16.20% | 15.79% | 13.92% | |
Share Based Compensation of Revenue |
1.52% | 2.12% | 2.08% | 2.05% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.20 | (0.07) | (0.06) | (0.11) | |
Depreciation/Fixed assets |
1.41 | 6.54 | 6.50 | 6.44 | |
Capex/Depreciation |
(0.29) | (0.06) | (0.06) | (0.06) | |
Revenue per Share |
18.01 | 16.43 | 16.88 | 18.63 | |
Operating CF per Share |
(0.32) | 0.34 | 0.30 | 0.48 | |
Capex per Share |
(0.28) | (0.30) | (0.29) | (0.27) | |
Capex to Sales |
0.02 | 0.02 | 0.02 | 0.01 | |
Net Profit Margin |
(8.81%) | (30.88%) | (28.26%) | (24.37%) |
Columns are period end dates